Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Voyageur Pharmaceuticals Ltd
VYYRF
Primary Symbol:
V.VM
Healthcare
Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX...
, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:VM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(83)
•••
2021Gamble
X
View Profile
View Bullboard History
Comment by
2021Gamble
on Apr 01, 2024 9:31am
RE:RE:RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
Well, I certainly hope they have products in the pipeline ... I mean really.... but until they're approved, they are only in the pipeline - so yes, under development ok, that's all good and
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Apr 01, 2024 9:26am
RE:RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
Obviously you missed the new info.....12 products, not the 5 they have talked about for years.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(83)
•••
2021Gamble
X
View Profile
View Bullboard History
Comment by
2021Gamble
on Apr 01, 2024 8:03am
RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
That was quite the day in the market actually, the day that was announced - I believe the high on the day was 0.69 or something, so some got a 10 bagger that day - slowly settled since then of course,
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Apr 01, 2024 7:58am
RE:RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
Her is a link to their product pipeline and stage the products are at. Pipeline – Voyageur Pharmaceuticals The only reason I am still in this stock is because of the very big upside but that will
...more
(5)
•••
Mork102
X
View Profile
View Bullboard History
Comment by
Mork102
on Apr 01, 2024 7:17am
RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
Obviously you haven't been a shareholder for long the announcements of health Canada approval sent the stock to over 30 cents however not a single solitary sale lots of hype from management but
...more
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 31, 2024 11:23pm
RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
First I hear of this.... The Corporation is developing 12 barium contrast products (HDXba, MultiXba, MultiXthin, MutiXS, SmoothX, BarXnectar, BarXthin, BarXhoney, Barpudding
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Mar 27, 2024 10:20am
RE:10% Equity Incentive Plan
Not going to debate you on this one.
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Post by
WarrantOfficer
on Mar 27, 2024 8:42am
Update MD&A Link
Search (sedarplus.ca) Search (sedarplus.ca)
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Post by
WarrantOfficer
on Mar 27, 2024 8:37am
10% Equity Incentive Plan
SO they issue themselves 3.7 million options. Fiscal 2023 issued a total of 2.9 million options and 1.3 million DSU's. IMO, a 10% Equity Incentive Plan is much to generous. I have attached
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 26, 2024 4:46pm
New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
(TheNewswire)Calgary, Alberta, Canada / TheNewswire / March 26, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company"), announces that it has filed its annual audited financial statements and management's discussion and analysis for the year ended November 30,...
read article.
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Post by
whitenorth72
on Mar 18, 2024 7:24pm
Up on the pink sheets.
$0.050 0.0495 | 9,900.00% Bid: 0.00 x 0 Ask: 0.00 x 0 Volume: 700 USD | PINK | REALTIME |
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Mar 14, 2024 4:12pm
RE:Burn Baby Burn
biggdogg, I like your positivity and man do I have a lot of reasons to hope you are right and the sooner the better!
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Mar 14, 2024 1:57pm
Burn Baby Burn
This comment is what I am most interested in after reviewing the news. The preparation of a carbon production Revenue Sharing Agreement is underway to exploit carbon captured and leverage the
...more
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Mar 13, 2024 3:55pm
RE:RE:RE:New Press Release - Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
I agree whitenorth72. The pharma field is frightening competitive. Releasing details of Royalty Agreements could turn catastrophic. Competitiors always ready to pounce. Patiently waiting for release
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden